why choose us

First received: November 19, 2025

Clinical Trial: A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple Countries

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hereditary Angioedema (HAE)

Study Type: OBSERVATIONAL


Official Title: A Multi-national Real-world Outcomes and Treatment Patterns Study of Lanadelumab (Takhzyro) in Paediatric Patients With Hereditary Angioedema (TAHORA)

Brief Summary: HAE is a rare condition. It causes sudden swelling under the skin and inside the body, like in the belly, throat, or genitals. This swelling happens because of a temporary leak in blood vessels but does not cause itching or hives. HAE is classified based on the amount of a protein in the blood called C1 inhibitor (C1-INH): HAE with normal C1-INH levels and HAE with limited or insufficient C1-INH levels (C1-INH deficiency). This study will concentrate on children with HAE C1-INH deficiency who have received…

Read more